NovaBridge Biosciences Payments to Acquire Debt Securities, Available-for-sale
NovaBridge Biosciences (NBP) reported Payments to Acquire Debt Securities, Available-for-sale of $51.12 million for the 12-month period ending 2024-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-04-07
- NovaBridge Biosciences payments to acquire debt securities, available-for-sale for the quarter ending 2024-12-31 was $0.00.
- NovaBridge Biosciences payments to acquire debt securities, available-for-sale for the quarter ending 2024-09-30 was $32.12M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $32.12M derived: sum of 2 quarters · filed 2026-04-07 | $51.12M 20-F · filed 2026-04-07 | |
| 2024-09-30 | $32.12M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $51.12M 6-K · filed 2025-12-18 | ||
| 2024-06-30 | $19.00M 6-K · filed 2025-10-06 |